2009 News Archive
Click on the links below to read the full story.
December 2009
Dr Trevor Perrior, Director of Research for Domainex has been appointed Visiting Professor of Medicinal Chemistry at the University of Sussex.
October 2009
Domainex Ltd has released the next generation of its LeadBuilder virtual screening technology.
LeadBuilder has been designed to be ideally suited to the needs of university groups engaged in Translational Research, and to emerging biotechnology and pharmaceutical companies.
July 2009
Domainex announced an extension of its research agreement with Ark Therapeutics.
Under the terms of the agreement Domainex will continue to provide Ark with hit-finding and lead optimization services for drug discovery against novel and exciting therapeutic targets nominated by the company.
June 2009
Domainex provides drug discovery services to St George's London and The University of Manchester in a £ 4million asthma treatment collaboration funded by The Wellcome Trust Seeding Drug Discovery Initiative.
May 2009
Natural products drug company Hypha Discovery signs deal with Domainex to support its research programme on novel oncology drugs
March 2009
Domainex has intellectual property rights to its Combinatorial Domain Hunting technology granted in Japan
March 2009
Domainex announced a collaboration on exciting drug discovery programmes with the Breakthrough Breast Cancer Research Centre and The Institute of Cancer Research to identify and develop inhibitors of two recently validated breast cancer targets, tankyrase and IKK-epsilon.
January 2009
Domainex will be sponsoring and presenting at PEGS - The Protein Expression Summit, which will be held in Boston MA, 6-10 April 2009.
